The role of the ubiquitin proteasome pathway in keratin intermediate filament protein degradation

Proceedings of the American Thoracic Society

Volumn 7, Issue 1, 2010, Pages 71-76

  Rogel, Micah R ^a   Jaitovich, Ariel ^a   Ridge, Karen M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Degradation; Intermediate filaments; Ubiquitin proteasome pathway

Indexed keywords

INTERMEDIATE FILAMENT PROTEIN; KERATIN; PROTEASOME; UBIQUITIN; UBIQUITIN PROTEIN LIGASE;

AGGRESOME; EPITHELIUM CELL; HUMAN; HYPOXIA; LUNG INJURY; MECHANICAL STRESS; NONHUMAN; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; REVIEW; ANIMAL; CHEMISTRY; ENZYMOLOGY; LUNG; LUNG ALVEOLUS; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; INTERMEDIATE FILAMENT PROTEINS; KERATINS; LUNG; PROTEASOME ENDOPEPTIDASE COMPLEX; PULMONARY ALVEOLI; SIGNAL TRANSDUCTION; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES;

EID: 77953264742     PISSN: 15463222     EISSN: 19435665     Source Type: Journal    
DOI: 10.1513/pats.200908-089JS     Document Type: Review

References (50)

1. Pickart CM. Mechanisms underlying ubiquitination. Annu Rev Biochem 2001;70:503-533. (Pubitemid 32663902)
2. Ciechanover A, Schwartz AL. The ubiquitin-proteasome pathway: the complexity and myriad functions of proteins death. Proc Natl Acad Sci USA 1998;95:2727-2730. (Pubitemid 28135795)
3. Lorick KL, Jensen JP, Fang S, Ong AM, Hatakeyama S, Weissman AM. RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc Natl Acad Sci USA 1999;96:11364-11369.
4. Honda R, Yasuda H. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. EMBO J 1999;18:22-27. (Pubitemid 29005019)
5. Lee PS, Wang Y, Dominguez MG, Yeung YG, Murphy MA, Bowtell DD, Stanley ER. The Cbl protooncoprotein stimulates csf-1 receptor multiubiquitination and endocytosis, and attenuates macrophage proliferation. EMBO J 1999;18:3616-3628. (Pubitemid 29308842)
6. Goldberg AL. Protein degradation and protection against misfolded or damaged proteins. Nature 2003;426:895-899. (Pubitemid 38056882)
7. Groll M, Ditzel L, Lowe J, Stock D, Bochtler M, Bartunik HD, Huber R. Structure of 20S proteasome from yeast at 2.4 A resolution. Nature 1997;386:463-471. (Pubitemid 27164066)
8. Lowe J, Stock D, Jap B, Zwickl P, Baumeister W, Huber R. Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 Å resolution. Science 1995;268:533-539.
9. Glickman MH, Rubin DM, Coux O, Wefes I, Pfeifer G, Cjeka Z, Baumeister W, Fried VA, Finley D. A subcomplex of the proteasome regulatory particle required for ubiquitin-conjugate degradation and related to the cop9-signalosome and eif3. Cell 1998;94:615-623.
10. Kisselev AF, Akopian TN, Woo KM, Goldberg AL. The sizes of peptides generated from protein by mammalian 26 and 20 S proteasomes. Implications for understanding the degradative mechanism and antigen presentation. J Biol Chem 1999;274:3363-3371.
11. Tamura N, Lottspeich F, Baumeister W, Tamura T. The role of tricorn protease and its aminopeptidase-interacting factors in cellular protein degradation. Cell 1998;95:637-648. (Pubitemid 28544125)
12. Omary MB. "IF-pathies": A broad spectrum of intermediate filament-associated diseases. J Clin Invest 2009;119:1756-1762.
13. Fuchs E, Cleveland DW. A structural scaffolding of intermediate filaments in health and disease. Science 1998;279:514-519. (Pubitemid 28067272)
14. Herrmann H, Strelkov SV, Feja B, Rogers KR, Brettel M, Lustig A, Haner M, Parry DA, Steinert PM, Burkhard P, et al. The intermediate filament protein consensus motif of helix 2b: its atomic structure and contribution to assembly. J Mol Biol 2000;298:817-832.
15. Prahlad V, Yoon M, Moir RD, Vale RD, Goldman RD. Rapid movements of vimentin on microtubule tracks: kinesin-dependent assembly of intermediate filament networks. J Cell Biol 1998;143:159-170. (Pubitemid 28480525)
16. Windoffer R, Leube RE. Detection of cytokeratin dynamics by timelapse fluorescence microscopy in living cells. J Cell Sci 1999;112:4521-4534. (Pubitemid 30034802)
17. Herrmann H, Bar H, Kreplak L, Strelkov SV, Aebi U. Intermediate filaments: from cell architecture to nanomechanics. Nat Rev Mol Cell Biol 2007;8:562-573. (Pubitemid 46985377)
18. Omary MB, Coulombe PA, McLean WH. Intermediate filament proteins and their associated diseases. N Engl J Med 2004;351:2087-2100. (Pubitemid 39482502)
19. Lowe J, Blanchard A, Morrell K, Lennox G, Reynolds L, Billett M, Landon M, Mayer RJ. Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle, and Mallory bodies in alcoholic liver disease. J Pathol 1988;155:9-15.
20. Ku NO, Michie SA, Soetikno RM, Resurreccion EZ, Broome RL, Oshima RG, Omary MB. Susceptibility to hepatotoxicity in transgenic mice that express a dominant-negative human keratin 18 mutant. J Clin Invest 1996;98:1034-1046. (Pubitemid 26293323)
21. Denk H, Stumptner C, Zatloukal K. Mallory bodies revisited. J Hepatol 2000;32:689-702. (Pubitemid 30180391)
22. Denk H, Franke WW, Eckerstorfer R, Schmid E, Kerjaschki D. Formation and involution of Mallory bodies ("Alcoholic hyalin") in murine and human liver revealed by immunofluorescence microscopy with antibodies to prekeratin. Proc Natl Acad Sci USA 1979;76:4112-4116. (Pubitemid 9249034)
23. Jagirdar J, Irie T, French SW, Patil J, Schwarz R, Paronetto F. Globular Mallory-like bodies in renal cell carcinoma: report of a case and review of cytoplasmic eosinophilic globules. Hum Pathol 1985;16:949-952. (Pubitemid 15238277)
24. Pasquinelli G, Preda P, Martinelli GN, Galassi A, Santini D, Venza E. Filamentous inclusions in nonneoplastic and neoplastic pancreas: an ultrastructural and immunogold labeling study. Ultrastruct Pathol 1995;19:495-500.
25. Nonomura A, Kono N, Ohta G. Pulmonary cytoplasmic hyalin resembling Mallory's alcoholic hyalin in the liver. Acta Pathol Jpn 1986;36:869-878. (Pubitemid 16091778)
26. Hazan R, Denk H, Franke WW, Lackinger E, Schiller DL. Change of cytokeratin organization during development of Mallory bodies as revealed by a monoclonal antibody. Lab Invest 1986;54:543-553. (Pubitemid 16072489)
27. Riley NE, Li J, McPhaul LW, Bardag-Gorce F, Lue YH, French SW. Heat shock proteins are present in Mallory bodies (cytokeratin aggresomes) in human liver biopsy specimens. Exp Mol Pathol 2003;74:168-172.
28. Riley NE, Bardag-Gorce F, Montgomery RO, Li J, Lungo W, Lue YH, French SW. Microtubules are required for cytokeratin aggresome (Mallory body) formation in hepatocytes: an in vitro study. Exp Mol Pathol 2003;74:173-179.
29. Franke WW, Denk H, Schmid E, Osborn M, Weber K. Ultrastructural, biochemical, and immunologic characterization of Mallory bodies in livers of griseofulvin-treated mice. Fimbriated rods of filaments containing prekeratin-like polypeptides. Lab Invest 1979;40:207-220.
30. Ridge KM, Linz L, Flitney FW, Kuczmarski ER, Chou YH, Omary MB, Sznajder JI, Goldman RD. Keratin 8 phosphorylation by protein kinase C delta regulates shear stress-mediated disassembly of keratin intermediate filaments in alveolar epithelial cells. J Biol Chem 2005;280:30400-30405. (Pubitemid 41216223)
31. Cadrin M, Anderson NM, Aasheim LH, Kawahara H, Franks DJ, French SW. Modifications in cytokeratin and actin in cultured liver cells derived from griseofulvin-fed mice. Lab Invest 1995;72:453-460.
32. Jaitovich A, Mehta S, Na N, Ciechanover A, Goldman RD, Ridge KM. Ubiquitin-proteasome-mediated degradation of keratin intermediate filaments in mechanically stimulated a549 cells. J Biol Chem 2008;283:25348-25355.
33. Yuan QX, Nagao Y, Gaal K, Hu B, French SW. Mechanisms of Mallory body formation induced by okadaic acid in drug-primed mice. Exp Mol Pathol 1998;65:87-103. (Pubitemid 28553041)
34. Nan L, Dedes J, French BA, Bardag-Gorce F, Li J, Wu Y, French SW. Mallory body (cytokeratin aggresomes) formation is prevented in vitro by p38 inhibitor. Exp Mol Pathol 2006;80:228-240.
35. Wu Y, Nan L, Bardag-Gorce F, Li J, French BA, Wilson LT, Dedes J, French SW. The role of laminin-integrin signaling in triggering MB formation. An in vivo and in vitro study. Exp Mol Pathol 2005;79:1-8. (Pubitemid 40984745)
36. Ku NO, Azhar S, Omary MB. Keratin 8 phosphorylation by p38 kinase regulates cellular keratin filament reorganization: modulation by a keratin 1-like disease causing mutation. J Biol Chem 2002;277:10775-10782. (Pubitemid 34952830)
37. Bardag-Gorce F, French BA, Nan L, Song H, Nguyen SK, Yong H, Dede J, French SW. Cyp2e1 induced by ethanol causes oxidative stress, proteasome inhibition and cytokeratin aggresome (Mallory body-like) formation. Exp Mol Pathol 2006;81:191-201. (Pubitemid 44665867)
38. Bardag-Gorce F, Riley NE, Nan L, Montgomery RO, Li J, French BA, Lue YH, French SW. The proteasome inhibitor, ps-341, causes cytokeratin aggresome formation. Exp Mol Pathol 2004;76:9-16. (Pubitemid 38096313)
39. Johnston JA, Ward CL, Kopito RR. Aggresomes: a cellular response to misfolded proteins. J Cell Biol 1998;143:1883-1898. (Pubitemid 29022611)
40. French SW. Present understanding of the development of Mallory's body. Arch Pathol Lab Med 1983;107:445-450. (Pubitemid 13043091)
41. Denk H, Franke WW. Rearrangement of the hepatocyte cytoskeleton after toxic damage: involution, dispersal and peripheral accumulation of Mallory body material after drug withdrawal. Eur J Cell Biol 1981;23:241-249. (Pubitemid 11148442)
42. Omary MB, Ku O-N, Price D, editors. Keratin modifications and solubility properties in epithelial cells and in vitro. New York: Plenum Press; 1998.
43. Loeb KR, Haas AL. Conjugates of ubiquitin cross-reactive protein distribute in a cytoskeletal pattern. Mol Cell Biol 1994;14:8408-8419. (Pubitemid 24373590)
44. Ku NO, Omary MB. Keratins turn over by ubiquitination in a phosphorylation-modulated fashion. J Cell Biol 2000;149:547-552. (Pubitemid 30252389)
45. Ni N CN, Litvan J, Ridge KM. Mitochondrial reactive oxygen species are required for hypoxia-induced degradation of keratin intermediate filaments. FASEB J [Epub ahead of print on 2009 Nov 6 as doi: 10.1096/fj.08-128967].
46. Zwickl P, Voges D, Baumeister W. The proteasome: a macromolecular assembly designed for controlled proteolysis. Philos Trans R Soc Lond B Biol Sci 1999;354:1501-1511. (Pubitemid 29464081)
47. Biederer T, Volkwein C, Sommer T. Degradation of subunits of the Sec61p complex, an integral component of the ER membrane, by the ubiquitin-proteasome pathway. EMBO J 1996;15:2069-2076. (Pubitemid 26141123)
48. Zatloukal K, Spurej G, Rainer I, Lackinger E, Denk H. Fate of Mallory body-containing hepatocytes: disappearance of Mallory bodies and restoration of the hepatocytic intermediate filament cytoskeleton after drug withdrawal in the griseofulvin-treated mouse. Hepatology 1990;11:652-661. (Pubitemid 20151744)
49. Bence NF, Sampat RM, Kopito RR. Impairment of the ubiquitinproteasome system by protein aggregation. Science 2001;292:1552-1555. (Pubitemid 32493425)
50. Gu LH, Coulombe PA. Keratin function in skin epithelia: a broadening palette with surprising shades. Curr Opin Cell Biol 2007;19:13-23. (Pubitemid 46123973)